COMMON STOCK PURCHASE WARRANT To Purchase 75,000 Shares of Common Stock of ELITE PHARMACEUTICALS, INC.Elite Pharmaceuticals Inc /De/ • November 14th, 2007 • Pharmaceutical preparations
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [___________] (the “Initial Holder” and together with any permitted assignee, the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Initial Exercise Date (as defined in Section 2) and on or prior to the close of business on the five year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Elite Pharmaceuticals, Inc., a Delaware corporation (the “Company”), up to Seventy-Five Thousand (75,000) shares (the “Warrant Shares”) of Common Stock, par value $.01 per share, of the Company (the “Common Stock”). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
ContractConsulting Agreement • November 14th, 2007 • Elite Pharmaceuticals Inc /De/ • Pharmaceutical preparations • New York
CONSULTING AGREEMENT, dated as of September 4, 2007, (this “Agreement”) by and between ELITE PHARMACEUTICALS, INC., a Delaware corporation with its principal place of business located at 165 Ludlow Avenue, Northvale, NJ 07467 (the “Company”), on the one hand, and Bridge Ventures, Inc., a Florida corporation, with offices located at 1241 Gulf of Mexico Drive, Sarasota, Florida 34228 (“Bridge”), and Saggi Capital Inc., a Florida corporation, with offices located at 500 West Highway 316, Citra, Florida 32113 (“Saggi”, together with Bridge, the “Consultants”), on the other hand.
ContractConsulting Agreement • November 14th, 2007 • Elite Pharmaceuticals Inc /De/ • Pharmaceutical preparations • New York
CONSULTING AGREEMENT, dated as of July 27, 2007, (this “Agreement”) by and between ELITE PHARMACEUTICALS, INC., a Delaware corporation with its principal place of business located at 165 Ludlow Avenue, Northvale, NJ 07467 (the “Company”), and Willstar Consultants, Inc. (the “Consultant”).
